1.
Design and Development of Tools for Risk Evaluation of Diabetes and Cardiovascular Disease in Community Pharmacy.
2.
Discrepancies Between Medical and Pharmacy Records for Patients on Anti-HIV Drugs
Failure to continue lipid-lowering drug use following the withdrawal of cerivastatin
Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies
Adaptation and validation of PCNE drug-related problem classification v6.2 in French-speaking Belgian community pharmacies.
3.
4.
5.
Effects of electronic communication between the GP and the pharmacist. The quality of medication data on admission and after discharge